Cardiovascular Toxicities of Androgen Deprivation Therapy-Reference-Cited by-同舟云学术

Cardiovascular Toxicities of Androgen Deprivation Therapy

Published:2021-04-17 Issue:6 Volume:22 Page:
ISSN:1527-2729
Container-title:Current Treatment Options in Oncology
language:en
Short-container-title:Curr. Treat. Options in Oncol.

Author:

Challa Azariyas A.,Calaway Adam Christopher,Cullen Jennifer,Garcia Jorge,Desai Nihar,Weintraub Neal L.,Deswal Anita,Kutty Shelby,Vallakati Ajay,Addison Daniel,Baliga Ragavendra,Campbell Courtney M.,Guha Avirup^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Oncology

Link

https://link.springer.com/content/pdf/10.1007/s11864-021-00846-z.pdf

Reference104 articles.

1. American Cancer Society. Key statistics in prostate cancer. 2019 [cited 2019 17 May]; Available from: https://www.cancer.org/cancer/prostate-cancer/about/key-statistics.html.Revised.

2. Zhou Y, Bolton EC, Jones JO. Androgens and androgen receptor signaling in prostate tumorigenesis. J Mol Endocrinol. 2015;54(1):R15–29.

3. Packer JR, Maitland NJ. The molecular and cellular origin of human prostate cancer. Biochim Biophys Acta. 2016;1863(6 Pt A):1238–60.

4. Shahinian VB, Kuo YF, Gilbert SM. Reimbursement policy and androgen-deprivation therapy for prostate cancer. N Engl J Med. 2010;363(19):1822–32.

5. Scherr D, Swindle PW, Scardino PT. National Comprehensive Cancer Network guidelines for the management of prostate cancer. Urology. 2003;61(2 Suppl 1):14–24.

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Understanding Perceptions of Care Coordination and Chronic Illness Management among Black Breast and Prostate Cancer Survivors and Providers;Journal of Ambulatory Care Management;2024-08-23

2. Health Literacy, Individual and Community Engagement, and Cardiovascular Risks and Disparities;JACC: CardioOncology;2024-06

3. Social Determinants of Health Mediate Racial Disparities in Cardiovascular Disease in Men With Prostate Cancer;JACC: CardioOncology;2024-06

4. Cardiovascular Toxicity Associated With Androgen Receptor Axis-Targeted Agents in Patients With Prostate Cancer: A Meta-analysis of Randomized Controlled Trials;Clinical Genitourinary Cancer;2024-06

5. Androgen Signaling in Prostate Cancer: When a Friend Turns Foe;Endocrine, Metabolic & Immune Disorders - Drug Targets;2024-05-31